McDonald’s says it's closing down CosMc’s, a new restaurant format it began piloting in the U.S. last year. But the company said on Friday that beverages inspired by CosMc’s will ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 ...

mRNA is incredibly delicate ... The team made about 100 ionizable lipids and introduced ester linkages into the carbon chains of the lipids to help make them more biodegradable, he recalls.

The mRNA platform market holds significant opportunities, driven by advancements in LNP delivery systems, codon optimization, and synthetic biology tools like CRISPR-Cas9. These innovations support ...

Moderna's advanced logistics tech tackles temperature challenges, minimizes shipping risks, and ensures critical medical products reach their destination safely.

Moderna voluntarily pressed pause on its request to license its vaccine candidate, mRNA-1083 — which combines vaccines for seasonal influenza and covid and is intended for people over 50 — until it ...

Article originally published by. FE fundinfo is not responsible for its content or accuracy and may not share the author’s views. News and research are not personal recommendations to deal. All ...

CompanyOverview\|NASDAQ:MRNA] Moderna Inc. (NASDAQ: MRNA) is down 35% in 2025, making it one of the worst-performing stocks ...

New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.

A San Diego biotech company is helping top research labs develop mRNA vaccines, including a vaccine for some types of cancer. Jaime Chambers reports. STORY: fox5sandiego.com ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7% in the afternoon session after the FDA ...